文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

氨甲环酸对接受非维生素K口服抗凝药患者拔牙后出血的影响:EXTRACT-NOAC随机临床试验

Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial.
PubMed 文献 · PLoS Med · 2021-05-03

EXTRACT-NOAC是一项随机、双盲、安慰剂对照、多中心临床试验,旨在评估10%氨甲环酸(TXA)漱口水能否减少服用非维生素K口服抗凝药(NOAC)患者拔牙后出血。共218例患者纳入全分析集,TXA组106例,安慰剂组112例。结果显示,TXA组与安慰剂组拔牙后7天内出血患者比例分别为26.4%和28.6%(相对风险0.92,95%CI 0.60-1.42,P=0.72),差异无统计学意义;但TXA组延迟性出血和多次拔牙后出血发生率较低。

要点

  • TXA漱口水未显著降低NOAC患者拔牙后7天内出血患者比例。
  • TXA组延迟性出血(率比0.32,95%CI 0.12-0.89)和多次拔牙后出血(率比0.40,95%CI 0.20-0.78)较低。
  • 围手术期出血和早期出血两组间无显著差异。

核心结论

  • 在服用NOAC并接受拔牙的患者中,TXA漱口水与安慰剂相比未显著降低围手术期或术后早期口腔出血率。
  • TXA可能减少延迟性出血以及多颗牙拔除后的术后口腔出血。

研究设计与样本

  • EXTRACT-NOAC为随机、双盲、安慰剂对照、多中心临床试验。
  • 共222例患者随机分组,218例纳入全分析集,其中TXA组106例,安慰剂组112例。
  • TXA组年龄74.8(±8.8)岁,男性81例;安慰剂组年龄72.7(±10.7)岁,男性64例。
  • 干预为10%TXA或安慰剂漱口水,拔牙前使用一次,之后每日3次共3天。
  • 主要结局为拔牙后7天内发生任何口腔出血的患者数。

主要发现

  • TXA组28例(26.4%)发生拔牙后出血,安慰剂组32例(28.6%),相对风险0.92(95%CI 0.60-1.42,P=0.72)。
  • TXA组共46次出血,安慰剂组85次出血,率比0.57(95%CI 0.31-1.05,P=0.07)。
  • 围手术期出血评分TXA组4±1.78,安慰剂组4±1.82(P=0.80)。
  • 早期出血率比0.76(95%CI 0.42-1.37);延迟性出血率比0.32(95%CI 0.12-0.89)。
  • 多次拔牙后出血率比0.40(95%CI 0.20-0.78)。

临床怎么用

  • 对于服用NOAC接受拔牙的患者,TXA漱口水可能有助于减少延迟性出血和多次拔牙后出血。
  • 围手术期及术后早期出血的预防效果尚不明确,需结合个体风险评估。

局限性

  • 试验因无效性分析而提前终止。
  • 患者依从性基于随访期间自我报告信息评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oral bleeding after dental extraction in patients on non-vitamin K oral anticoagulants (NOACs) is a frequent problem. We investigated whether 10% tranexamic acid (TXA) mouthwash decreases post-extraction bleeding in patients treated with NOACs. METHODS AND FINDINGS: The EXTRACT-NOAC study is a randomized, double-blind, placebo-controlled, multicenter, clinical trial. Patients were randomly assigned to 10% TXA or placebo mouthwash and were instructed to use the mouthwash once prior to dental extraction, and thereafter for 3 times a day for 3 days. The primary outcome was the number of patients with any post-extraction oral bleeding up to day 7. Secondary outcomes included periprocedural, early, and delayed bleeding, and the safety outcomes included all thrombotic events. The first patient was randomized on February 9, 2018 and the last patient on March 12, 2020. Of 222 randomized patients, 218 patients were included in the full analysis set, of which 106 patients were assigned to TXA (74.8 (±8.8) years; 81 men) and 112 to placebo (72.7 (±10.7) years; 64 men). Post-extraction bleeding occurred in 28 (26.4%) patients in the TXA group and in 32 (28.6%) patients in the placebo group (relative risk, 0.92; 95% confidence interval [CI], 0.60 to 1.42; P = 0.72). There were 46 bleeds in the TXA group and 85 bleeds in the placebo group (rate ratio, 0.57; 95% CI, 0.31 to 1.05; P = 0.07). TXA did not reduce the rate of periprocedural bleeding (bleeding score 4 ± 1.78 versus 4 ± 1.82, P = 0.80) and early bleeding (rate ratio, 0.76; 95% CI, 0.42 to 1.37). Delayed bleeding (rate ratio, 0.32; 95% CI, 0.12 to 0.89) and bleeding after multiple extractions (rate ratio, 0.40; 95% CI, 0.20 to 0.78) were lower in the TXA group. One patient in the placebo group had a transient ischemic attack while interrupting the NOAC therapy in preparation for the dental extraction. Two of the study limitations were the premature interruption of the trial following a futility analysis and the assessment of the patients' compliance that was based on self-reported information during follow-up. CONCLUSIONS: In patients on NOACs undergoing dental extraction, TXA does not seem to reduce the rate of periprocedural or early postoperative oral bleeding compared to placebo. TXA appears to reduce delayed bleeds and postoperative oral bleeding if multiple teeth are extracted. TRIAL REGISTRATION: ClinicalTrials.gov NCT03413891 EudraCT; EudraCT number:2017-001426-17; EudraCT Public website: eudract.ema.europa.eu.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Ockerman A, Miclotte I, Vanhaverbeke M, et al. Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial. PLoS Med. 2021. PMID: 33939696. doi:10.1371/journal.pmed.1003601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。